Oruka Therapeutics, Inc.
ORKA$1.72B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMENLO PARK28 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Sep 15, 2026
26wMarket Overview
Stock performance and key metrics
ORKA News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ORKA-001 Induction Dose | Phase 2 | Plaque Psoriasis | - | - |
ORKA-001 | Phase 2 | Plaque Psoriasis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply